Possible association of the pro-melanin-concentrating hormone gene with a Greater body mass index as a side effect of the antipsychotic olanzapine

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 144, Issue 8, 2007, Pages 1063-1069

  Chagnon, Y C ^a   Bureau, A ^a   Gendron, D ^a   Bouchard, R H ^a   Merette C ^a   Roy, M A ^a   Maziade, M ^a  

^a CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

Drugs; Obesity; Pharmacogenetics; Pharmacogenomics; Schizophrenia; Side effects; Weight

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GENDER; GENE; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PHARMACOGENETICS; PHENOTYPE; PMCH GENE; PRIORITY JOURNAL; SCHIZOPHRENIA; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE DISTRIBUTION; AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; HYPOTHALAMIC HORMONES; LINKAGE (GENETICS); MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN PRECURSORS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SEX DISTRIBUTION; WEIGHT GAIN;

EID: 36749070913     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30554     Document Type: Article

References (26)

1. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ. 1999. Antipsychotic-induced weight gain: A comprehensive research synthesis. Am J Psychiatry 156:1686-1696.
2. Anonymous. 2004. Consensus development conference on antipsychotic drugs and obesity and diabetes. Obes Res 12:362-368.
3. Basile VS, Masellis M, De Luca V, Meltzer HY, Kennedy JL. 2002. 759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain. Lancet 360:1790-1791.
4. Chagnon YC. 2006. Susceptibility genes for the side effect of antipsychotics on body weight and obesity. Pharmacogenet Pharmacogenom Curr Drug Targets 7:1681-1695.
5. Chagnon YC, Merette C, Bouchard RH, Emond C, Roy M-A, Maziade M. 2004. A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses. Mol Psychiatry 9:1067-1074.
6. Ellingrod VL, Perry PJ, Ringold JC, Lund BC, Bever-Stille K, Fleming F, Holman TL, Miller D. 2005. Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine. Am J Med Genet Part B 134B:76-78.
7. Gibson WT, Pissios P, Trombly DJ, Luan J, Keogh J, Wareham NJ, Maratos-Flier E, O'Rahilly S, Farooqi IS. 2004. Melanin-concentrating hormone receptor mutations and human obesity: Functional analysis. Obes Res 12:743-749.
8. Gonzalez MI, Baker BI, Hole DR, Wilson CA. 1998. Behavioral effects of neuropeptide E-I (NEI) in the female rat: Interactions with alpha-MSH, MCH, and dopamine. Peptides 19:1007-1016.
9. Hirji KF, Mehta CR, Patel NR. 1987. Computing Distributions for Exact Logistic Regression. J Am Stat Assoc 82:1110-1117.
10. Kerwin RW, Mancama DT, Arranz MJ. 2001. Genetic strategies for the personalization of antipsychotic treatment. Expert Rev Mol Diagn 1:275-280.
11. Maziade M, Roy MA, Chagnon YC, Cliche D, Fournier JP, Montgrain N, Dion C, Lavallee JC, Garneau Y, Gingras N, Nicole L, Pires A, Ponton AM, Potvin A, Wallot H, Merette C. 2005. Shared and specific susceptibility loci for schizophrenia and bipolar disorder: A dense genome scan in Eastern Quebec families. Mol Psychiatry 10:486-499.
12. Maziade M, Roy M-A, Fournier J-P, Cliche D, Mérette C, Caron C, Garneau Y, Montgrain N, Shriqui C, Dion C, Nicole L, Potvin A, Lavallée JC, Pires A, Raymond V. 1992. Reliability of best-estimate diagnosis in genetic linkage studies of major psychoses. Results from the Québec pedigrees studies. Am J Psychiatry 149:1674-1686.
13. Miller D, Ellingrod VL, Holman TL, Buckley PF, Arndt S. 2005. Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism. Am J Med Genet Part B 133B:97-100.
14. National Heart L, and Blood Institute. 1998. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. National Institute of Health, National Heart, Lung, and Blood Institute 228 p.
15. Presse F, Nahon JL, Fischer WH, Vale W. 1990. Structure of the human melanin concentrating hormone mRNA. Mol Endocrinol 4:632-637.
16. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek R, Kanarek R, Maratos-Flier E. 1996. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380:243-247.
17. Reynolds GP, Zhang Z, Zhang X. 2003. Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain. Am J Psychiatry 160:677-679.
18. Reynolds GP, Zhang ZJ, Zhang XB. 2002. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 359:2086-2087.
19. Roth BL, Sheffler DJ, Kroeze WK. 2004. Magic shotguns versus magic bullets: Selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3:353-359.
20. Sanchez M, Baker BI, Celis M. 1997. Melanin-concentrating hormone (MCH) antagonizes the effects of alpha-MSH and neuropeptide E-I on grooming and locomotor activities in the rat. Peptides 18:393-396.
21. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E. 1998. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396:670-674.
22. Stanton JM. 1995. Weight gain associated with neuroleptic medication: A review. Schizophr Bull 21:463-472.
23. Templeman LA, Reynolds GP, Arranz B, San L. 2005. Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenet Genomics 15:195-200.
24. Theisen FM, Haberhausen M, Firnges MA, Gregory P, Reinders JH, Remschmidt H, Hebebrand J, Antel J. 2006. No evidence for binding of clozapine, olanzapine and/or haloperidol to selected receptors involved in body weight regulation. Pharmacogenomics J Advance online publication, 19 September 2006: 10.1038/sj.tpj. 6500418
25. Tsai SJ, Hong CJ, Yu YW, Lin CH. 2002. -759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain. Lancet 360:1790.
26. Zhang ZJ, Yao ZJ, Mou XD, Chen JF, Zhu RX, Liu W, Zhang XR, Sun J, Hou G. 2003. Association of -2548G/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain. Zhonghua Yi Xue Za Zhi 83:2119-2123.